Regorafenib Assessment in Refractory Advanced Colorectal Cancer(RegARd-C) (RegARd-C)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01929616 |
Recruitment Status :
Completed
First Posted : August 28, 2013
Last Update Posted : June 25, 2019
|
Sponsor:
Jules Bordet Institute
Information provided by (Responsible Party):
Jules Bordet Institute
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | May 13, 2016 |
Actual Study Completion Date : | June 17, 2019 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):